We are live on ! Find out more
GRTS

Gritstone bio, Inc. Common Stock
GRTS

Delisted

GRTS was delisted on the 21st of October, 2024.

Back to rankings

88 hedge funds and large institutions have $99.5M invested in Gritstone bio, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 26 increasing their positions, 25 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,154% more call options, than puts

Call options by funds: $991K | Put options by funds: $79K

4% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 25

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4% less first-time investments, than exits

New positions opened: 25 | Existing positions closed: 26

2% less funds holding

Funds holding: 90 → 88 (-2)

23% less capital invested

Capital invested by funds: $129M → $99.5M (-$29.1M)

Holders
88
Holders Change
-2
Holders Change %
-2.22%
% of All Funds
1.38%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
25
Increased
26
Reduced
25
Closed
26
Calls
$991K
Puts
$79K
Net Calls
+$912K
Net Calls Change
+$92K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$10M
2
APM
Avidity Partners Management
Texas
+$6.48M
3
State Street
State Street
Massachusetts
+$2.9M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$2.18M
5
Ensign Peak Advisors
Ensign Peak Advisors
Utah
+$1.59M

Top Sellers

Rank Fund Capital Flow
1
FLSM
Frazier Life Sciences Management
California
-$6.46M
2
Bank of America
Bank of America
North Carolina
-$2.39M
3
ECM
Endurant Capital Management
California
-$1.5M
4
Marshall Wace
Marshall Wace
United Kingdom
-$1.17M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$1.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$14.8M -$249K -106,187 -1%
RG
2
Redmile Group
California
$13.4M -$156K -66,700 -1%
BlackRock
3
BlackRock
New York
$12.1M +$10M +4,280,777 +221%
Vanguard Group
4
Vanguard Group
Pennsylvania
$7.9M +$909K +388,103 +11%
VVM
5
Versant Venture Management
California
$6.94M – – –
APM
6
Avidity Partners Management
Texas
$5.39M +$6.48M +2,765,500 New
FLSM
7
Frazier Life Sciences Management
California
$4.68M -$6.46M -2,760,634 -53%
Balyasny Asset Management
8
Balyasny Asset Management
Illinois
$3.67M -$1.15M -490,982 -21%
Morgan Stanley
9
Morgan Stanley
New York
$3.47M -$129K -55,199 -3%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$3.27M +$2.18M +931,478 +125%
State Street
11
State Street
Massachusetts
$2.95M +$2.9M +1,239,007 +453%
Millennium Management
12
Millennium Management
New York
$2.53M +$1.37M +584,219 +82%
Assenagon Asset Management
13
Assenagon Asset Management
Luxembourg
$2.43M -$679K -290,104 -19%
Ensign Peak Advisors
14
Ensign Peak Advisors
Utah
$1.56M +$1.59M +677,353 +562%
Fidelity Investments
15
Fidelity Investments
Massachusetts
$1.54M -$19.2K -8,197 -1%
Northern Trust
16
Northern Trust
Illinois
$1.39M +$1.31M +557,939 +366%
PAI
17
Palo Alto Investors
California
$1.3M – – –
Citadel Advisors
18
Citadel Advisors
Florida
$859K -$275K -117,417 -21%
HFRG
19
Houlihan Financial Resource Group
Virginia
$816K +$843K +360,000 New
N
20
Nuveen
North Carolina
$666K +$800K +341,449 New
BFM
21
Boothbay Fund Management
New York
$589K +$124K +53,085 +21%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$565K +$564K +240,903 +491%
UBS Group
23
UBS Group
Switzerland
$521K +$127K +54,391 +26%
Charles Schwab
24
Charles Schwab
California
$458K +$470K +200,640 +590%
Dimensional Fund Advisors
25
Dimensional Fund Advisors
Texas
$399K -$281K -119,869 -37%
1
2 3 4 5

GRTS Hedge Fund Activity: Q2 2023 in Review

88 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Gritstone bio, Inc. Common Stock (GRTS) for Q2 2023, worth a combined $99.5M — down 23% from $129M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of GRTS and 25 opened new positions — a net loss of 1 holder — while 25 trimmed existing stakes and 26 added.

The largest buyer was BlackRock, adding an estimated $10M. The largest seller was Frazier Life Sciences Management, cutting an estimated $6.46M.

  • 88 institutional investors held Gritstone bio, Inc. Common Stock (GRTS) as of Q2 2023, down from 90 in Q1 2023.
  • Funds reported $99.5M of Gritstone bio, Inc. Common Stock stock for Q2 2023, down 23% quarter-over-quarter.
  • 25 funds opened new Gritstone bio, Inc. Common Stock positions in Q2 2023 and 26 closed out, a net change of -1 holder.
  • The largest Gritstone bio, Inc. Common Stock buyer in Q2 2023 was BlackRock, an estimated $10M added.
  • The largest Gritstone bio, Inc. Common Stock seller in Q2 2023 was Frazier Life Sciences Management, an estimated $6.46M sold.

Based on aggregated 13F filings for Q2 2023.